| 3 years | 1.94 |  | 6.71 |
| 5 years | 1.94 | | 12.75 |
| 10 years | 1.94 | | 18.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Castagna
CEO | Chief Executive Officer | 49 | 2025-10-06 |
| Director of Finance/CFO | 50 | 2025-10-06 | |
David Thomson
SEC | Corporate Secretary | 59 | 2025-10-06 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Castagna
BRD | Director/Board Member | 49 | 2025-10-06 |
David Thomson
BRD | Director/Board Member | 59 | 2025-10-06 |
| Director/Board Member | 50 | 2025-10-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/7/25 | Issuer sale | Director | 72,174 | 0.1442% | ||
| 10/7/25 | Issuer sale | Director | 84,422 | 0.1687% | ||
| 10/7/25 | Issuer sale | Director | 49,750 | 0.0994% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 305M | |
| -0.70% | +4.58% | +40.23% | +138.79% | 1,271B | |
| +1.11% | +4.11% | +45.85% | +92.54% | 683B | |
| -0.18% | +2.15% | +26.25% | +112.46% | 520B | |
| -0.38% | +3.69% | +39.60% | +69.51% | 389B | |
| -0.16% | +0.01% | +60.69% | +44.94% | 362B | |
| +0.18% | +0.95% | +27.05% | +58.76% | 304B | |
| +0.34% | +0.27% | +3.51% | +36.30% | 286B | |
| -0.22% | +1.47% | +38.89% | +74.73% | 253B | |
| -1.05% | +0.23% | +36.10% | +121.22% | 208B | |
| Average | -0.10% | +1.73% | +35.35% | +83.25% | 475B | |
| Weighted average by Cap. | -0.13% | +2.67% | +37.43% | +96.77% |
Employees
163
Sector
Pharmaceuticals
